Prof. M.J. Kersten MD PhD publications

foto

Publications Prof. MD PhD M.J. Kersten

Position
Full Professor
Main activities
Patient care, Research
Specialisation
Biology and treatment of lymphoma, with an emphasis on early clinical trials
Focus of research

Marie José Kersten is a professor of hematology and head of the department of Hematology at the Academic Medical Center in Amsterdam. B cell malignancies are the main focus of research in this department, which together with the departments of Pathology and Experimental Immunology forms the basis for the LYMMCARE Institute (Lymphoma and Myeloma Center Amsterdam). Marie José Kersten is involved in several research projects and she is the principal investigator for several phase I/II clinical trials focusing on the biology and treatment of NHL, Waldenstrom’s macroglobulinemia and Hodgkin lymphoma. She has recently been appointed as chair of the newly established EHA (European Hematology Association) Scientific Working Group Lymphoma. She is the co-chair of the HOVON (Hemato-Oncologie Volwassenen Nederland) Lymphoma Working Party, and a co-founder and member of the Board of the Lunenburg Lymphoma Phase I/II Consortium (LLPC). The main focus of the LLPC is to perform early clinical trials (from first-in-man trials to early phase II trials) in patients with lymphoma. She is also an active member of the Lunenburg Lymphoma Biomarker Consortium (LLBC), the European Waldenstrom’s Macroglobulinemia Consortium (EWMC) and the HOVON Myeloma Working Party. Another research theme within LYMMCARE is to better understand the biology underlying tumor growth, progression and treatment resistance (in lymphoma, Waldenstrom's macroglobulinemia and multiple myeloma). This research is done in collaboration with the pathology department at the AMC (Pals/Spaargaren).
 

2021

  • Dinnessen Manette A. W., Visser Otto, Tonino Sanne H., Posthuma Eduardus F. M., Blijlevens Nicole M. A., Kersten Marie José, Lugtenburg Pieternella J., Dinmohamed Avinash G. Conditional relative survival among patients with follicular lymphoma: a population-based study in the Netherlands Blood cancer journal 2021;11 (1) [PubMed]
  • Ren Zemin, Lantermans Hildo, Kuil Annemieke, Kraan Willem, Arenzana-Seisdedos Fernando, Kersten Marie José, Spaargaren Marcel, Pals Steven T. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma JOURNAL OF HEMATOLOGY & ONCOLOGY 2021;14 (1) [PubMed]

2020

  • Owen Roger G., McCarthy Helen, Rule Simon, D'Sa Shirley, Thomas Sheeba K., Tournilhac Olivier, Forconi Francesco, Kersten Marie José, Zinzani Pier Luigi, Iyengar Sunil, Kothari Jaimal, Minnema Monique C., Kastritis Efstathios, Aurran-Schleinitz Thérèse, Cheson Bruce D., Walter Harriet, Greenwald Daniel, Chen Dih-Yih, Frigault Melanie M., Hamdy Ahmed, Izumi Raquel, Patel Priti, Wei Helen, Lee Sun Ku, Mittag Diana, Furman Richard R. Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study Lancet. Haematology 2020;7 (2):e112-e121 [PubMed]
  • Michot Jean-Marie, Bouabdallah Reda, Vitolo Umberto, Doorduijn Jeanette K., Salles Gilles, Chiappella Annalisa, Zinzani Pier Luigi, Bijou Fontanet, Kersten Marie José, Sarmiento Rafael, Mosulen Silvia, Mendez Cristina, Uttamsingh Shailaja, Pourdehnad Michael, Hege Kristen, Chen Tianlei, Klein Christian, Hagner Patrick R., Nikolova Zariana, Ribrag Vincent Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study Lancet. Haematology 2020;7 (9):e649-e659 [PubMed]
  • Doorduijn Jeanette K., Zijlstra Josee M., Lugtenburg Pieternella J., Kersten Marie Josee, Böhmer Lara H., Minnema Monique C., MacKenzie Marius A., van Marwijk Kooij Rien, de Jongh Eva, Snijders Tjeerd J. F., de Weerdt Okke, van Gelder Michel, Hoogendoorn Mels, Leys Rineke B. L., Kibbelaar Robby E., de Jong Daphne, Chitu Dana A., van’t Veer Mars B., Kluin-Nelemans Hanneke C. Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial British journal of haematology 2020;190 (3):385-393 [PubMed]
  • Kersten Marie José, Spanjaart Anne Mea, Thieblemont Catherine CD19-directed CAR T-cell therapy in B-cell NHL Current opinion in oncology 2020;32 (5):408-417 [PubMed]
  • Castillo Jorge J., Advani Ranjana H., Branagan Andrew R., Buske Christian, Dimopoulos Meletios A., D'Sa Shirley, Kersten Marie José, Leblond Veronique, Minnema Monique C., Owen Roger G., Palomba M. Lia, Talaulikar Dipti, Tedeschi Alessandra, Trotman Judith, Varettoni Marzia, Vos Josephine M., Treon Steven P., Kastritis Efstathios Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia Lancet. Haematology 2020;7 (11):e827-e837
  • Stuij Sebastiaan M., Drossaert Constance H. C., Labrie Nanon H. M., Hulsman Robert L., Kersten Marie José, van Dulmen Sandra, Smets Ellen M. A., de Haes Hanneke, Pieterse Arwen, van Weert Julia, Christoph Noor Developing a digital training tool to support oncologists in the skill of information-provision: A user centred approach BMC medical education 2020;20 (1) [PubMed]
  • Stevens Wendy B. C., Bakunina Katerina, Cuijpers Marloes, Chamuleau Martine, Beeker Aart, Fijnheer Rob, Hebart Holger, Visser Hein P. J., Doorduijn Jeanette K., Linton Kim, Dreyling Martin, de Jong Daphne, Kersten Marie José HOVON110/ReBeL Study: Results of the phase i part of a randomized phase I/II study of lenalidomide, rituximab with or without bendamustine in patients with relapsed/refractory follicular lymphoma HemaSphere 2020;4 (1) [PubMed]
  • Lantermans Hildo C., Minderman Marthe, Kuil Annemieke, Kersten Marie-José, Pals Steven T., Spaargaren Marcel Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma Leukemia 2020 [PubMed]
  • Wang M., Munoz J., Goy A., Locke F. L., Jacobson C. A., Hill B. T., Timmerman J. M., Holmes H., Jaglowski S., Flinn I. W., McSweeney P. A., Miklos D. B., Pagel J. M., Kersten M. J., Milpied N., Fung H., Topp M. S., Houot R., Beitinjaneh A., Peng W., Zheng L., Rossi J. M., Jain R. K., Rao A. V., Reagan P. M. KTE-X19 CAR T-Cell therapy in relapsed or refractory mantle-cell lymphoma New England journal of medicine 2020;382 (14):1331-1342 [PubMed]
  • Yakoub-Agha Ibrahim, Chabannon Christian, Bader Peter, Basak Grzegorz W., Bonig Halvard, Ciceri Fabio, Corbacioglu Selim, Duarte Rafael F., Einsele Hermann, Hudecek Michael, Kersten Marie José, Köhl Ulrike, Kuball J. rgen, Mielke Stephan, Mohty Mohamad, Murray John, Nagler Arnon, Robinson Stephen, Saccardi Riccardo, Sanchez-Guijo Fermin, Snowden John A., Srour Micha, Styczynski Jan, Urbano-Ispizua Alvaro, Hayden Patrick J., Kröger Nicolaus Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) Haematologica 2020;105 (2):297-316 [PubMed]
  • van Vulpen Jonna K, Sweegers Maike G., Peeters Petra H M, Courneya Kerry S, Newton Robert U, Aaronson Neil K, Jacobsen Paul B, Galvão Daniel A, Chinapaw Mai J, Steindorf Karen, Irwin Melinda L, Stuiver Martijn M, Hayes Sandi, Griffith Kathleen A, Mesters Ilse, Knoop Hans, Goedendorp Martine M, Mutrie Nanette, Daley Amanda J, McConnachie Alex, Bohus Martin, Thorsen Lene, Schulz Karl-Heinz, Short Camille E, James Erica L, Plotnikoff Ronald C, Schmidt Martina E, Ulrich Cornelia M, van Beurden Marc, Oldenburg Hester S, Sonke Gabe S, van Harten Wim H, Schmitz Kathryn H, Winters-Stone Kerri M, Velthuis Miranda J, Taaffe Dennis R, van Mechelen Willem, Kersten Marie José, Nollet Frans, Wenzel Jennifer, Wiskemann Joachim, Verdonck-de Leeuw Irma M, Brug Johannes, May Anne M, Buffart Laurien M Moderators of Exercise Effects on Cancer-related Fatigue: A Meta-analysis of Individual Patient Data Medicine and science in sports and exercise 2020;52 (2):303-314 [PubMed]
  • Vermaat Joost S., Somers Sebastiaan F., de Wreede Liesbeth C., Kraan Willem, de Groen Ruben A. L., Schrader Anne M. R., Kerver Emile D., Scheepstra Cornelis G., Berenschot Henriëtte, Deenik Wendy, Wegman Jurgen, Broers Rianne, de Boer Jan-Paul D., Nijland Marcel, van Wezel Tom, Veelken Hendrik, Spaargaren Marcel, Cleven Arjen H., Kersten Marie José, Pals Steven T. MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis Haematologica 2020;105 (2):424-434 [PubMed]
  • Douma Joeri A. J., de Beaufort Maaike B., Kampshoff Caroline S., Persoon Saskia, Vermaire Jorine A., Chinapaw Mai J., van Mechelen Willem, Nollet Frans, Kersten Marie José, Smit Jan H., Verdonck-de Leeuw Irma M., Altenburg Teatske M., Buffart Laurien M. Physical activity in patients with cancer: self-report versus accelerometer assessments Supportive care in cancer 2020;28 (8):3701–3709 [PubMed]
  • Driessen Julia, Visser Otto, Zijlstra Josée M., Lugtenburg Pieternella J., Plattel Wouter J., Kersten Marie José, Dinmohamed Avinash G. Primary therapy and relative survival in classical Hodgkin lymphoma: a nationwide population-based study in the Netherlands, 1989–2017 Leukemia 2020 [PubMed]
  • Posthuma Hidde L. A., Zijlstra Josée M., Visser Otto, Lugtenburg Pieternella J., Kersten Marie José, Dinmohamed Avinash G. Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016 British journal of haematology 2020;189 (1):117-121 [PubMed]
  • Lehmann Vicky, Labrie Nanon H. M., van Weert Julia C. M., van Dulmen Sandra, de Haes Hanneke J. C. J. M., Kersten Marie José, Pieterse Arwen H., Smets Ellen M. A. Provider caring and structuring treatment information to improve cancer patients’ recall: Does it help? Patient education and counseling 2020;103 (1):55-62 [PubMed]
  • Lugtenburg Pieternella Johanna, de Nully Brown Peter, van der Holt Bronno, D'Amore Francesco A., Koene Harry R., de Jongh Eva, Fijnheer Rob, van Esser Joost W., Bohmer Lara H., Pruijt Johannes F., Verhoef Gregor E., Hoogendoorn Mels, Bilgin Memis Y., Nijland Marcel, van der Burg-de Graauw Nicole C., Oosterveld Margreet, Jie Kon-Siong G., Larsen Thomas Stauffer, van der Poel Marjolein W., Leijs Maria B., Silbermann Matthijs H., van Marwijk Kooy Marinus, Beeker Aart, Kersten Marie J., Doorduijn Jeanette K., Tick Lidwine W., Brouwer Rolf E., Lam King H., Burggraaff Coreline N., de Keizer Bart, Arens Anne I., de Jong Daphne, Hoekstra Otto S., Zijlstra-Baalbergen Josee M. Rituximab-chop with early rituximab intensification for diffuse large b-cell lymphoma: A randomized phase iii trial of the hovon and the nordic lymphoma group (hovon-84) Journal of clinical oncology 2020;38 (29):3377-3387 [PubMed]
  • Dinnessen Manette A. W., van der Poel Marjolein W. M., Tonino Sanne H., Visser Otto, Blijlevens Nicole M. A., de Jong Daphne, Lam King H., Kersten Marie José, Lugtenburg Pieternella J., Dinmohamed Avinash G. Stage-specific trends in primary therapy and survival in follicular lymphoma: a nationwide population-based analysis in the Netherlands, 1989–2016 Leukemia 2020 [PubMed]
  • Lehmann Vicky, Labrie Nanon H. M., van Weert Julia C. M., van Dulmen Sandra, de Haes Hanneke J. C. J. M., Kersten Marie José, Pieterse Arwen H., Smets Ellen M. A. Tailoring the amount of treatment information to cancer patients’ and survivors’ preferences: Effects on patient-reported outcomes Patient education and counseling 2020;103 (3):514-520 [PubMed]
  • Greidanus Michiel A., de Boer Angela G. E. M., de Rijk Angelique E., Brouwers Sonja, de Reijke Theo M., Kersten Marie José, Klinkenbijl Jean H. G., Lalisang Roy I., Lindeboom Robert, Zondervan Patricia J., Frings-Dresen Monique H. W., Tamminga Sietske J. The Successful Return-To-Work Questionnaire for Cancer Survivors (I-RTW_CS): Development, Validity and Reproducibility PATIENT-PATIENT CENTERED OUTCOMES RESEARCH 2020;13 (5):567-582 [PubMed]
  • Awasthi Rakesh, Pacaud Lida, Waldron Edward, Tam Constantine S., Jäger Ulrich, Borchmann Peter, Jaglowski Samantha, Foley Stephen Ronan, van Besien Koen, Wagner-Johnston Nina D., Kersten Marie José, Schuster Stephen J., Salles Gilles, Maziarz Richard T., Anak Özlem, del Corral Christopher, Chu Jufen, Gershgorin Irina, Pruteanu-Malinici Iulian, Chakraborty Abhijit, Mueller Karen Thudium, Waller Edmund K. Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL Blood advances 2020;4 (3):560-572 [PubMed]
  • Chamuleau Martine E. D., Burggraaff Coreline N., Nijland Marcel, Bakunina Katerina, Mous Rogier, Lugtenburg Pieternella J., Dierickx Daan, van Imhoff Gustaaf W., Vermaat Joost S. P., Marijt Eric A. F., Visser Otto, Mandigers Caroline, Bilgin Yavuz M., Beeker Aart, Durian Mark F., van Rees Bas P., Bohmer Lara H., Tick Lidwine W., Boersma Rinske S., Snijders Tjeerd J. F., Schouten Harry C., Koene Harry R., de Jongh Eva, Hijmering Nathalie, Diepstra Arjan, van de Berg Anke, Arens Anne I. J., Huijbregts Julia, Hoekstra Otto, Zijlstra Josee M., de Jong Daphne, Kersten Marie José Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus phaselenalidomide: II HOVON trial results of a multicenter Haematologica 2020;105 (12):2805-2812 [PubMed]

2019

  • Minnema Monique C., Nasserinejad Kazem, Hazenberg Bouke, Hegenbart Ute, Vlummens Philip, Ypma Paula F., Kröger Nicolaus, Wu Ka Lung, Kersten Marie Jose, Schaafsma M. Ron, Croockewit Sandra, de Waal Esther, Zweegman Sonja, Tick Lidwien, Broijl Annemieke, Koene Harry, Bos Gerard, Sonneveld Pieter, Schönland Stefan Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: Results of the multicenter HOVON 104 trial Haematologica 2019;104 (11):2274-2282 [PubMed]
  • Labrie Nanon, van Dulmen Sandra, Kersten Marie José, de Haes Hanneke J. C. M., Pieterse Arwen H., van Weert Julia C. M., van Spronsen Dick Johan, Smets Ellen M. A. Effective information provision about the side effects of treatment for malignant lymphoma: Protocol of a randomized controlled trial using video vignettes Journal of medical Internet research 2019;21 (5) [PubMed]
  • Sweegers Maike G., Altenburg Teatske M., Brug Johannes, May Anne M., van Vulpen Jonna K., Aaronson Neil K., Arbane Gill, Bohus Martin, Courneya Kerry S., Daley Amanda J., Galvao Daniel A., Garrod Rachel, Griffith Kathleen A., van Harten Wim H., Hayes Sandra C., Herrero-Román Fernando, Kersten Marie J., Lucia Alejandro, McConnachie Alex, van Mechelen Willem, Mutrie Nanette, Newton Robert U., Nollet Frans, Potthoff Karin, Schmidt Martina E., Schmitz Kathryn H., Schulz Karl Heinz, Sonke Gabe, Steindorf Karen, Stuiver Martijn M., Taaffe Dennis R., Thorsen Lene, Twisk Jos W., Velthuis Miranda J., Wenzel Jennifer, Winters-Stone Kerri M., Wiskemann Joachim, Paw Mai J. Chin A., Buffart Laurien M. Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: A meta-analysis of individual patient data British journal of sports medicine 2019;53 (13):812 [PubMed]
  • Bernard P., Savard J., Steindorf K., Sweegers M. G., Courneya K. S., Newton R. U., Aaronson N. K., Jacobsen P. B., May A. M., Galvao D. A., Chinapaw M. J., Stuiver M. M., Griffith K. A., Mesters I., Knoop H., Goedendorp M. M., Bohus M., Thorsen L., Schmidt M. E., Ulrich C. M., Sonke G. S., van Harten W., Winters-Stone K. M., Velthuis M. J., Taaffe D. R., van Mechelen W., Kersten M. J., Nollet F., Wenzel J., Wiskemann J., Verdonck-de Leeuw I. M., Brug J., Buffart L. M. Effects and moderators of exercise on sleep in adults with cancer: Individual patient data and aggregated meta-analyses Journal of psychosomatic research 2019;124 [PubMed]
  • van Sandwijk Marit S., Al Arashi Doaa, van de Hare F.M., van der Torren J.M.R., Kersten Marie J., Bijlsma Joost A., Berge Ineke J. M. Ten, Bemelman Frederike J. Fatigue, Anxiety, Depression and Quality of Life in Kidney Transplant Recipients, Haemodialysis Patients, Patients with a Haematological Malignancy and Healthy Controls Nephrology, dialysis, transplantation 2019;34 (5):833-838 [PubMed]
  • Hoving V. , Kersten M. J. , Minnema M. C., de Bruin P. C., Vos Josephine Hoe behandel ik IgM-M-proteïne-gerelateerde AL-amyloïdose? Nederlands tijdschrift voor hematologie 2019;16:87-91
  • van Dongen Johanna M., Persoon Saskia, Jongeneel Gabrielle, Bosmans Judith E., Kersten Marie José, Brug Johannes, Nollet Frans, Chinapaw Mai J. M., Buffart Laurien M. Long-term effectiveness and cost-effectiveness of an 18-week supervised exercise program in patients treated with autologous stem cell transplantation: results from the EXIST study Journal of cancer survivorship 2019;13 (4):558-569 [PubMed]
  • de Groen Ruben A. L., Schrader Anne M. R., Kersten Marie José, Pals Steven T., Vermaat Joost S. P. MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications Haematologica 2019;104 (12):2337-2348 [PubMed]
  • Vos Josephine M. I. On Waldenström’s macroglobulinemia and IgM related disorders 2019. 153p. ISBN 9789463612111. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kersten M.J. , Pals S. T.; Co-supervisors: Treon S. P. , Minnema M. C.)
  • Hagenbeek Anton, Mooij Hans, Zijlstra Josée, Lugtenburg Pieternella, van Imhoff Gustaaf, Nijland Marcel, Tonino Sanne, Hutchings Martin, Spiering Marjolein, Liu Roberto, van Tinteren Harm, Kersten Marie José Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study Haematologica 2019;104 (4):e151-e153 [PubMed]
  • Wester Ruth, van der Holt Bronno, Asselbergs Emelie, Zweegman Sonja, Kersten Marie Jose, Vellenga Edo, van Marwijk Kooy Marinus, de Weerdt Okke, Minnema Monique, Lonergan Sarah, Palumbo Antonio, Lokhorst Henk, Broijl Annemiek, Sonneveld Pieter Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial Haematologica 2019;104 (11):2265-2273 [PubMed]
  • Rosenwald Andreas, Bens Susanne, Advani Ranjana, Barrans Sharon, Copie-Bergman Christiane, Elsensohn Mad-Helenie, Natkunam Yaso, Calaminici Maria, Sander Birgitta, Baia Maryse, Smith Alexandra, Painter Daniel, Pham Luu, Zhao Shuchun, Ziepert Marita, Jordanova Ekaterina S., Molina Thierry J., Kersten Marie José, Kimby Eva, Klapper Wolfram, Raemaekers John, Schmitz Norbert, Jardin Fabrice, Stevens Wendy B. C., Hoster Eva, Hagenbeek Anton, Gribben John G., Siebert Reiner, Gascoyne Randy D., Scott David W., Gaulard Philippe, Salles Gilles, Burton Catherine, de Jong Daphne, Sehn Laurie H., Maucort-Boulch Delphine Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: A study by the Lunenburg Lymphoma Biomarker Consortium Journal of clinical oncology 2019;37 (35):3359-3368 [PubMed]
  • Kleijwegt Fleur S., Roda Afnan Abdul, Rolvink José, Kater Arnon P., Kersten Marie José, Vos Josephine M. I. Rare but Serious: Ibrutinib Induced Liver Failure HemaSphere 2019;3 (6):e307 [PubMed]
  • Persoon S., Buffart L. M., Chinapaw M. J. M., Nollet F., Frings-Dresen M. H., Koning S., Kersten M. J., Tamminga S. J. Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy Supportive care in cancer 2019;27 (8):2987-2997 [PubMed]
  • Lugtenburg Pieternella J., Zijlstra Josee M., Doorduijn Jeanette K., Böhmer Lara H., Hoogendoorn Mels, Berenschot Henriette W., Beeker Aart, van der Burg-de Graauw Nicole C., Schouten Harry C., Bilgin Yavuz M., Kersten Marie-Jose, Koene Harry R., Herbers Alexandra H. E., de Jong Daphne, Hijmering Nathalie, Lam King H., Chiţu Dana, Brouwer Rolf E., van Imhoff Gustaaf W. Rituximab-PECC induction followed by 90Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study British journal of haematology 2019;187 (3):347-355 [PubMed]
  • Bahjat Mahnoush, de Wilde Guus, van Dam Tijmen, Maas Chiel, Bloedjes Timon, Bende Richard J, van Noesel Carel J M, Luijks Dieuwertje M, Eldering Eric, Kersten Marie José, Guikema Jeroen E J The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors Cell cycle (Georgetown, Tex.) 2019;18 (18):2307-2322 [PubMed]
  • Schuster Stephen J., Bishop Michael R., Tam Constantine S., Waller Edmund K., Borchmann Peter, McGuirk Joseph P., Jäger Ulrich, Jaglowski Samantha, Andreadis Charalambos, Westin Jason R., Fleury Isabelle, Bachanova Veronika, Foley S. Ronan, Ho P. Joy, Mielke Stephan, Magenau John M., Holte Harald, Pantano Serafino, Pacaud Lida B., Awasthi Rakesh, Chu Jufen, Anak Özlem, Salles Gilles, Maziarz Richard T., Study group members AMC , Kersten Marie José J., Biemond Bart J., Burger Patrick, Claessen Marie-José J. A. G., Hazenberg Mette D., Kater Arnon P., Kemper E. M., Nur Erfan, Spiering Marjolein, Tonino Sanne H., Voermans Carlijn, Zeerleder Sacha S. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma New England journal of medicine 2019;380 (1):45-56 [PubMed]
  • Kersten Marie José, van Ettekoven Cornelis N., Heijink D. Ianne M. Unexpected neurologic complications following a novel lymphoma treatment 'expected' to give rise to neurologic toxicity BMJ case reports 2019;12 (11) [PubMed]
  • Kastritis E., Leblond V., Dimopoulos M. A., Kimby E., Staber P., Kersten M. J., Tedeschi A., Buske C. Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of oncology 2019;30 (5):860-862 [PubMed]

2018

  • Goldschmidt H., Lokhorst H. M., Mai E. K., van der Holt B., Blau I. W., Zweegman S., Weisel K. C., Vellenga E., Pfreundschuh M., Kersten M. J., Scheid C., Croockewit S., Raymakers R., Hose D., Potamianou A., Jauch A., Hillengass J., Stevens-Kroef M., Raab M. S., Broijl A., Lindemann H. W., Bos G. M. J., Brossart P., van Marwijk Kooy M., Ypma P., Duehrsen U., Schaafsma R. M., Bertsch U., Hielscher T., Jarari Le, Salwender H. J., Sonneveld P. Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMGHD-4 trial Leukemia 2018;32 (2):383-390 [PubMed]
  • Michot J. M., Bouabdallah R., Doorduijn J. K., Vitolo U., Kersten M. J., Chiappella A., Zinzani P. L., Pourdehnad M., Nikolova Z., Ribrag V. CC-122, a novel cereblon-modulating agent, in combination with obinutuzumab (GA101) in patients with relapsed and refractory (R/R) B-cell non-hodgkin lymphoma (NHL) Annals of oncology 2018;29:iii9
  • Nijland Marieke L., Koens Lianne, Pals Steven T., ten Berge Ineke J. M., Bemelman Frederike J., Kersten Marie José Clinicopathological characteristics of T-NHL arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the literature Haematologica 2018;103 (3):486-496 [PubMed]
  • Stuij Sebastiaan M., Labrie Nanon H. M., van Dulmen Sandra, Kersten Marie José, Christoph Noor, Hulsman Robert L., Smets Ellen, Drossaert Stans, de Haes Hanneke, Pieterse Arwen, van Weert Julia Developing a digital communication training tool on information-provision in oncology: Uncovering learning needs and training preferences BMC medical education 2018;18 (1) [PubMed]
  • Kastritis E., Leblond V., Dimopoulos M. A., Kimby E., Staber P., Kersten M. J., Tedeschi A., Buske C. Erratum: Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Annals of oncology : official journal of the European Society for Medical Oncology (2018) 29 Suppl 4 (iv41-iv50)) Annals of oncology 2018;29:iv270 [PubMed]
  • Kater Arnon P., Tonino Sanne H., Spiering Marjolein, Chamuleau Martine E. D., Liu Roberto, Adewoye Adeboye Henry, Gao Jie, Dreiling Lyndah, Xin Yan, Doorduijn Jeanette K., Kersten Marie José Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies Blood cancer journal 2018;8 (2):16 [PubMed]
  • Schrader Anne M. R., Jansen Patty M., Willemze Rein, Vermeer Maarten H., Cleton-Jansen Anne-Marie, Somers Sebastiaan F., Veelken Hendrik, van Eijk Ronald, Kraan Willem, Kersten Marie José, van den Brand Michiel, Stevens Wendy B. C., de Jong Daphne, Hamid Myrurgia Abdul, Tanis Bea C., Posthuma Eduardus F. M., Nijland Marcel, Diepstra Arjan, Pals Steven T., Cleven Arjen H. G., Vermaat Joost S. P. High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma Blood 2018;131 (18):2086-2089 [PubMed]
  • Vos Josephine Mathilde, Notermans Nicolette C., D'Sa Shirley, Lunn Michael P., van der Pol W. Ludo, Kraan Willem, Reilly Mary M., Chalker Jane, Gupta Rajeev, Kersten Marie-José, Pals Steven T., Minnema Monique C. High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy Journal of neurology, neurosurgery, and psychiatry 2018;89 (9):1007-1009 [PubMed]
  • Koens Lianne, van de Ven Peter M., Hijmering Nathalie J., Kersten Marie J., Diepstra Arjan, Chamuleau Martine, de Jong Daphne Interobserver variation in CD30 immunohistochemistry interpretation; consequences for patient selection for targeted treatment Histopathology 2018;73 (3):473-482 [PubMed]
  • Persoon S., Chinapaw M. J. M., Buffart L. M., Brug J., Kersten M. J., Nollet F. Lessons learnt from a process evaluation of an exercise intervention in patients treated with autologous stem cell transplantation European journal of cancer care 2018;27 (1):e12779 [PubMed]
  • Tonino Sanne H., Deenik Wendy, Wegman Jurgen J., Kersten Marie J. Nieuwe Nederlandse richtlijn ‘Folliculair lymfoom’: een beknopte samenvatting voor de dagelijkse praktijk Nederlands tijdschrift voor hematologie 2018;15 (4):167-176
  • Persoon Saskia Physical exercise in patients treated with hematopoietic stem cell transplantation 2018. ISBN 9789490791629. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kersten M. J., Chin A Paw M. J. M.; Co-supervisors: Buffart L. M., Nollet F.)
  • Ren Zemin, van Andel Harmen, de Lau Wim, Hartholt Robin B., Maurice Madelon M., Clevers Hans, Kersten Marie José, Spaargaren Marcel, Pals Steven T. Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins Blood 2018;131 (9):982-944 [PubMed]
  • van de Donk Niels W. CJ, van der Holt Bronno, Minnema Monique C., Vellenga Edo, Croockewit Sandra, Kersten Marie José, von dem Borne Peter A., Ypma Paula, Schaafsma Ron, de Weerdt Okke, Klein Saskia K., Delforge Michel, Levin Mark-David, Bos Gerard M., Jie Kon-Siong G., Sinnige Harm, Coenen Jules L. LM, de Waal Esther G., Zweegman Sonja, Sonneveld Pieter, Lokhorst Henk M. Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial Lancet. Haematology 2018;5 (10):e479-e492 [PubMed]
  • Oosten L. E. M., Chamuleau M. E. D., Thielen F. W., de Wreede L. C., Siemes C., Doorduijn J. K., Smeekes O. S., Kersten M. J., Hardi L., Baars J. W., Demandt A. M. P., Stevens W. B. C., Nijland M., van Imhoff G. W., Brouwer R., Uyl-de Groot C. A., Kluin P. M., de Jong D., Veelken H. Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens Annals of hematology 2018;97 (2):255-266 [PubMed]
  • Brown Jennifer R., Hamadani Mehdi, Hayslip John, Janssens Ann, Wagner-Johnston Nina, Ottmann Oliver, Arnason Jon, Tilly Hervé, Millenson Michael, Offner Fritz, Gabrail Nashat Y., Ganguly Siddhartha, Ailawadh Sikander, Kasar Siddha, Kater Arnon P., Doorduijn Jeanette K., Gao Lei, Lager Joanne J., Wu Bin, Egile Coumaran, Kersten Marie José Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial Lancet. Haematology 2018;5 (4):e170-e180 [PubMed]
  • Kastritis E., Leblond V., Dimopoulos M. A., Kimby E., Staber P., Kersten M. J., Tedeschi A., Buske C. Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of oncology 2018;29:iv41-iv50 [PubMed]

2017

  • van Andel Harmen, Ren Zemin, Koopmans Iris, Joosten Sander P. J., Kocemba Kinga A., de Lau Wim, Kersten Marie José, de Bruin Alexander M., Guikema Jeroen E. J., Clevers Hans, Spaargaren Marcel, Pals Steven T. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins Proceedings of the National Academy of Sciences of the United States of America 2017;114 (2):376-381 [PubMed]
  • Franssen L. E., Roeven M. W. H., Hobo W., Doorn R., Oostvogels R., Falkenburg J. H. F., van de Donk N. W., Kester M. G. D., Fredrix H., Westinga K., Slaper-Cortenbach I., Spierings E., Kersten M. J., Dolstra H., Mutis T., Schaap N., Lokhorst H. M. A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma Bone marrow transplantation 2017;52 (10):1378-1383 [PubMed]
  • Vos Josephine M., Tsakmaklis Nickolas, Patterson Christopher J., Meid Kirsten, Castillo Jorge J., Brodsky Philip, Ganz Tomas, Pals Steven T., Kersten Marie José, Xu Lian, Yang Guang, Treon Steven P., Hunter Zachary R. CXCL13 levels are elevated in patients with Waldenstrom macroglobulinemia, and are predictive of major response to ibrutinib Haematologica 2017;102 (11):E452-E455 [PubMed]
  • Buffart Laurien M., Kalter Joeri, Sweegers Maike G., Courneya Kerry S., Newton Robert U., Aaronson Neil K., Jacobsen Paul B., May Anne M., Galvão Daniel A., Chinapaw Mai J., Steindorf Karen, Irwin Melinda L., Stuiver Martijn M., Hayes Sandi, Griffith Kathleen A., Lucia Alejandro, Mesters Ilse, van Weert Ellen, Knoop Hans, Goedendorp Martine M., Mutrie Nanette, Daley Amanda J., McConnachie Alex, Bohus Martin, Thorsen Lene, Schulz Karl-Heinz, Short Camille E., James Erica L., Plotnikoff Ron C., Arbane Gill, Schmidt Martina E., Potthoff Karin, van Beurden Marc, Oldenburg Hester S., Sonke Gabe S., van Harten Wim H., Garrod Rachel, Schmitz Kathryn H., Winters-Stone Kerri M., Velthuis Miranda J., Taaffe Dennis R., van Mechelen Willem, Kersten Marie-José, Nollet Frans, Wenzel Jennifer, Wiskemann Joachim, Verdonck-de Leeuw Irma M., Brug Johannes Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs Cancer treatment reviews 2017;52:91-104 [PubMed]
  • Minnema Monique C., Kimby Eva, D'Sa Shirley, Fornecker Luc-Matthieu, Poulain Stéphanie, Snijders Tom J., Kastritis Efstathios, Kremer Stéphane, Fitsiori Aikaterini, Simon Laurence, Davi Frédéric, Lunn Michael, Castillo Jorge J., Patterson Christopher J., Le Garff-Tavernier Magali, Costopoulos Myrto, Leblond Véronique, Kersten Marie-José, Dimopoulos Meletios A., Treon Steven P. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome Haematologica 2017;102 (1):43-51 [PubMed]
  • Persoon Saskia, Kersten Marie José, Buffart Laurien M., Vander Slagmolen Griet, Baars Joke W., Visser Otto, Manenschijn Annelies, Nollet Frans, Chinapaw Mai J. M. Health-related physical fitness in patients with multiple myeloma or lymphoma recently treated with autologous stem cell transplantation Journal of science and medicine in sport / Sports Medicine Australia 2017;20 (2):116-122 [PubMed]
  • D'Sa Shirley, Kersten Marie José, Castillo Jorge J., Dimopoulos Meletios, Kastritis Efstathios, Laane Edward, Leblond Véronique, Merlini Giampaolo, Treon Steven P., Vos Josephine M., Lunn Michael P. Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel British journal of haematology 2017;176 (5):728-742 [PubMed]
  • van Andel H., Kocemba K. A., de Haan-Kramer A., Mellink C. H., Piwowar M., Broijl A., van Duin M., Sonneveld P., Maurice M. M., Kersten M. J., Spaargaren M., Pals S. T. Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease Oncogene 2017;36 (15):2105-2115 [PubMed]
  • Stevens Wendy B. C., Mendeville Matias, Redd Robert, Clear Andrew J., Bladergroen Reno, Calaminici Maria, Rosenwald Andreas, Hoster Eva, Hiddemann Wolfgang, Gaulard Philippe, Xerri Luc, Salles Gilles, Klapper Wolfram, Phreundschuh Michael, Jack Andrew, Gascoyne Randy D., Natkunam Yasodha, Advani Ranjana, Kimby Eva, Sander Birgitta, Sehn Laurie, Hagenbeek Anton, Raemaekers John, Gribben John, Kersten Marie Jose', Ylstra Bauke, Weller Edie, de Jong Daphne Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium Haematologica 2017;102 (8):1413-1423 [PubMed]
  • Persoon Saskia, Chinapaw Mai J. M., Buffart Laurien M., Liu Roberto D. K., Wijermans Pierre, Koene Harry R., Minnema Monique C., Lugtenburg Pieternella J., Marijt Erik W. A., Brug Johannes, Nollet Frans, Kersten Marie José Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study PLoS ONE 2017;12 (7):e0181313 [PubMed]
  • Younes Anas, Ansell Stephen, Fowler Nathan, Wilson Wyndham, de Vos Sven, Seymour John, Advani Ranjana, Forero Andres, Morschhauser Franck, Kersten Marie Jose, Tobinai Kensei, Zinzani Pier Luigi, Zucca Emanuele, Abramson Jeremy, Vose Julie The landscape of new drugs in lymphoma Nature reviews. Clinical oncology 2017;14 (6):335-346 [PubMed]
  • Doorduijn Jeanette K., van Imhoff Gustaaf W., van der Holt Bronno, Schouten Harry C., Schaafsma Martijn R., MacKenzie Marius A., Baars Joke W., Kersten Marie José, Lugtenburg Pieternella J., van den Bent Martin J., Enting Roelien H., Spoelstra Fokje M., Poortmans Philip, Bromberg Jacoline E. C. Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study Hematological oncology 2017;35 (4):497-503 [PubMed]
  • Stuiver Martijn M., Kampshoff Caroline S., Persoon Saskia, Groen Wim, van Mechelen Willem, Chinapaw Mai J. M., Brug Johannes, Nollet Frans, Kersten Marie-José, Schep Goof, Buffart Laurien M. Validation and Refinement of Prediction Models to Estimate Exercise Capacity in Cancer Survivors Using the Steep Ramp Test Archives of physical medicine and rehabilitation 2017;98 (11):2167-2173 [PubMed]

2016

  • de Jong Antoinette, Kwee Thomas C., Quarles van Ufford Henriëtte M. E., Beek Frederik J. A., Quekel Lorentz G. B. A., de Klerk John M. H., Zijlstra Josée M., Fijnheer Rob, Ludwig Inge, Kersten Marie José, Stoker Jaap, Nievelstein Rutger A. J. Computed Tomography Observer Agreement in Staging Malignant Lymphoma Journal of computer assisted tomography 2016;40 (2):261-265 [PubMed]
  • Thijssen Rachel, ter Burg Johanna, Garrick Brett, van Bochove Gregor G. W., Brown Jennifer R., Fernandes Stacey M., Rodríguez María Solé, Michot Jean-Marie, Hallek Michael, Eichhorst Barbara, Reinhardt Hans Christian, Bendell Johanna, Derks Ingrid A. M., van Kampen Roel J. W., Hege Kristen, Kersten Marie José, Trowe Torsten, Filvaroff Ellen H., Eldering Eric, Kater Arnon P. Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia Blood 2016;128 (4):574-583 [PubMed]
  • Vos Josephine M. I., Kersten Marie-Jose, Kraan Willem, Groeneveld Onno N., Linn Cisca, Pals Steven T., Minnema Monique C. Effective treatment of Bing-Neel Syndrome with oral fludarabine: a case series of four consecutive patients British journal of haematology 2016;172 (3):461-464 [PubMed]
  • Nijland Marieke L., Kersten Marie José, Pals Steven T., Bemelman Frederike J., ten Berge Ineke J. M. Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management Transplantation direct 2016;2 (1):e48 [PubMed]
  • Hagenbeek A., Chamuleau M., van Imhoff G. W., Kersten M. J. Fase 1/2-studies bij non-hodgkinlymfomen, hodgkinlymfoom en chronische lymfatische leukemie Nederlands tijdschrift voor hematologie 2016;13 (8):347-349
  • Zijlstra Josée M., Burggraaff Coreline N., Kersten Marie José, Barrington Sally F. FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice? Haematologica 2016;101 (11):1279-1283 [PubMed]
  • de Rooij Martin F. M., Kuil Annemieke, Kraan Willem, Kersten Marie José, Treon Steven P., Pals Steven T., Spaargaren Marcel Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia Haematologica 2016;101 (3):e111-e115 [PubMed]
  • van Dalen Elvira C., Mank Arno, Leclercq Edith, Mulder Renée L., Davies Michelle, Kersten Marie José, van de Wetering Marianne D. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia Cochrane database of systematic reviews (Online) 2016;2016 (4):CD006247 [PubMed]
  • Moreau Philippe, Masszi Tamás, Grzasko Norbert, Bahlis Nizar J., Hansson Markus, Pour Ludek, Sandhu Irwindeep, Ganly Peter, Baker Bartrum W., Jackson Sharon R., Stoppa Anne-Marie, Simpson David R., Gimsing Peter, Palumbo Antonio, Garderet Laurent, Cavo Michele, Kumar Shaji, Touzeau Cyrille, Buadi Francis K., Laubach Jacob P., Berg Deborah T., Lin Jianchang, Di Bacco Alessandra, Hui Ai-Min, van de Velde Helgi, Richardson Paul G., Spencer Andrew, Grigg Andrew, He Simon, Joshua Douglas, Greil Richard, Kühr Thomas, Linkesch Werner, Sormann Siegfried, Ludwig Heinz, Robin Valérie, Schots Henri, Vekemans Marie-Christiane, Wu Ka Lung, Doyen Chantal, Song Kevin, Reiman Anthony, Shustik Chaim, Bahlis Nizar, Xu Yan, Jin Jie, Pour Luděk, Ščudla Vlastimil, Gregora Evžen, Kersten Marie José Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma New England journal of medicine 2016;374 (17):1621-1634 [PubMed]
  • Broijl Annemiek, Kersten Marie-José, Alemayehu Wendimagegn Ghidey, Levin Mark-David, de Weerdt Okke, Vellenga Edo, Meijer Ellen, Wittebol Shulamit, Tanis Bea C., Cornelisse Petra B., Stevens-Kroef Marian, Bos Gerard M. J., Wijermans Pierre W., Lokhorst Henk, Sonneveld Pieter Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma Haematologica 2016;101 (4):e149-e152 [PubMed]
  • Vos Josephine M., Gustine Joshua, Rennke Helmut G., Hunter Zachary, Manning Robert J., Dubeau Toni E., Meid Kirsten, Minnema Monique C., Kersten Marie-Jose, Treon Steven P., Castillo Jorge J. Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes British journal of haematology 2016;175 (4):623-630 [PubMed]
  • Pals Steven T., Kersten Marie José, Spaargaren Marcel Targeting cell adhesion and homing as strategy to cure Waldenström's macroglobulinemia Best practice & research. Clinical haematology 2016;29 (2):161-168 [PubMed]
  • Heijink D. M., Kater A. P., Hazenberg M. D., Hagenbeek A., Kersten M. J. T-cells fighting B-cell lymphoproliferative malignancies: the emerging field of CD19 CAR T-cell therapy Netherlands journal of medicine 2016;74 (4):147-151 [PubMed]
  • Thijssen Rachel The interplay between microenvironmental signaling and novel targeted drugs in CLL 2016. 171p. ISBN 9789461827333. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Eldering E. F., Kater A. P.; Co-supervisor: Kersten M. J.)
  • Thijssen R., ter Burg J., van Bochove G. G. W., de Rooij M. F. M., Kuil A., Jansen M. H., Kuijpers T. W., Baars J. W., Virone-Oddos A., Spaargaren M., Egile C., van Oers M. H. J., Eldering E., Kersten M. J., Kater A. P. The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells Leukemia 2016;30 (2):337-345 [PubMed]
  • Thijssen R., ter Burg J., van Bochove G. G. W., de Rooij M. F. M., Kuil A., Jansen M. H., Kuijpers T. W., Baars J. W., Virone-Oddos A., Spaargaren M., Egile C., van Oers M. H. J., Eldering E., Kersten M. J., Kater A. P. The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 ( voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells (Vol 30, pg 337, 2016) Leukemia 2016;30 (9):1963 [PubMed]

2015

  • Hengeveld P. J., Kersten M. J. B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy? Blood cancer journal 2015;5:e282 [PubMed]
  • Jak M., Kersten M. J. Behandeling van het non-hodgkin-lymfoom met antistoffen: nieuwe targets, nieuwe concepten Nederlands tijdschrift voor hematologie 2015;12 (7):245-252
  • Mank Arno P. M., Schoonenberg Charlot, Bleeker Kim, Heijmenberg Susanne, Heer Koen de, van Oers Marinus H. J., Kersten Marie José Early discharge after high dose chemotherapy is safe and feasible: a prospective evaluation of 6 years of home care Leukemia & lymphoma 2015;56 (7):2098-2104 [PubMed]
  • de Rooij Martin F. M., Kuil Annemieke, Kater Arnon P., Kersten Marie José, Pals Steven T., Spaargaren Marcel Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy Blood 2015;125 (14):2306-2309 [PubMed]
  • Kersten Marie José, Guikema Jeroen E. J. MYC in diffuse large B-cell lymphoma: always the bad guy? Leukemia & lymphoma 2015;56 (11):3003-3004 [PubMed]
  • Kersten Marie José, Visser Otto, Schouten Harry, Zweegman Sonja Oudere patiënten hebben baat bij nieuwe middelen Medisch contact 2015;70 (dec):11-13
  • Sonneveld Pieter, Asselbergs Emilie, Zweegman Sonja, van der Holt Bronno, Kersten Marie Jose, Vellenga Edo, van Marwijk-Kooy Marinus, Broyl Annemiek, de Weerdt Okke, Lonergan Sarah, Palumbo Antonio, Lokhorst Henk Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma Blood 2015;125 (3):449-456 [PubMed]
  • Vermaat Joost S., Pals Steven T., Younes Anas, Dreyling Martin, Federico Massimo, Aurer Igor, Radford John, Kersten Marie José Precision medicine in diffuse large B-cell lymphoma: hitting the target Haematologica 2015;100 (8):989-993 [PubMed]
  • Lokhorst Henk M., van der Holt Bronno, Cornelissen Jan J., Kersten Marie José, van Oers Marinus, Raymakers Reinier, Minnema Monique C., Zweegman Sonja, Bos Gerard, Schaap Nicolaas, Wittebol Shulamiet, de Weerdt Okke, Ammerlaan Rianne, Sonneveld Pieter Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival Haematologica 2015;100 (12):e508-e510 [PubMed]
  • Zweegman S., Lokhorst H. M., Levin M. D., de Waal E., Bos G. M. J., Kersten M. J., Croockewit A., Ypma P. F., Klein S. K., Minnema M. C., Sonneveld P. Richtlijn behandeling multipel myeloom 2015 Nederlands tijdschrift voor hematologie 2015;12 (8):279-302

2014

  • Scheid Christof, Sonneveld Pieter, Schmidt-Wolf Ingo G. H., van der Holt Bronno, el Jarari Laila, Bertsch Uta, Salwender Hans, Zweegman Sonja, Blau Igor Wolfgang, Vellenga Edo, Weisel Katja, Pfreundschuh Michael, Jie Kon-Siong, Neben Kai, van de Velde Helgi, Duehrsen Ulrich, Schaafsma M. Ron, Lindemann Walter, Kersten Marie José, Peter Norma, Hänel Mathias, Croockewit Sandra, Martin Hans, Wittebol Shulamiet, Bos Gerard Mj, van Marwijk-Kooy Marinus, Wijermans Pierre, Goldschmidt Hartmut, Lokhorst Henk M. Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial Haematologica 2014;99 (1):148-154 [PubMed]
  • Kersten M. J., Kraan W., Doorduijn J., Bromberg J., Lam K., Kluin P. M., van der Holt B. J., Spaargaren M., Pals S. T. Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations Blood cancer journal 2014;4:e266 [PubMed]
  • Kraan W., van Keimpema M., Horlings H. M., Schilder-Tol E. J. M., Oud M. E. C. M., Noorduyn L. A., Kluin P. M., Kersten M. J., Spaargaren M., Pals S. T. High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma Leukemia 2014;28 (3):719-720 [PubMed]
  • Thielen N., van der Holt B., Verhoef G. E. G., Ammerlaan Rianne A. H. M., Sonneveld P., Janssen J. J. W. M., Deenik W., Falkenburg J. H. F., Kersten M. J., Sinnige Harm A. M., Schipperus M., Schattenberg A., van Marwijk Kooy R., Smit W. M., Chu Isabel W. T., Valk Peter J. M., Ossenkoppele G. J., Cornelissen J. J. Hoge dosis imatinib versus hoge dosis imatinib in combinatie met intermediaire dosis cytarabine bij patienten met nieuw gediagnosticeerde chronische myeloïde leukemie Nederlands tijdschrift voor hematologie 2014;11 (3):113
  • Hart A., Baars J. W., Kersten M. J., Brandsma D., van Tinteren H., de Jong D., Spiering M., Dewit L., Boogerd W. Outcome of patients with primary central nervous system lymphoma treated outside clinical trials Netherlands journal of medicine 2014;72 (4):218-223 [PubMed]
  • Adams Hugo J. A., Kwee Thomas C., Lokhorst Henk M., Westerweel Peter E., Fijnheer Rob, Kersten Marie José, Verkooijen Helena M., Stoker Jaap, Nievelstein Rutger A. J. Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy Journal of magnetic resonance imaging 2014;39 (6):1394-1400 [PubMed]
  • de Jong Antoinette, Kwee Thomas C., de Klerk John M. H., Adam Judit A., de Keizer Bart, Fijnheer Rob, Kersten Marie José, Ludwig Inge, Jauw Yvonne W. S., Zijlstra Josée M., Pieters-van den Bos Indra C., Stoker Jaap, Hoekstra Otto S., Nievelstein Rutger A. J. Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma American journal of nuclear medicine and molecular imaging 2014;4 (3):231-238 [PubMed]
  • Sander Birgitta, de Jong Daphne, Rosenwald Andreas, Xie Wanling, Balagué Olga, Calaminici Maria, Carreras Joaquim, Gaulard Philippe, Gribben John, Hagenbeek Anton, Kersten Marie José, Molina Thierry Jo, Lee Abigail, Montes-Moreno Santiago, Ott German, Raemaekers John, Salles Gilles, Sehn Laurie, Thorns Christoph, Wahlin Björn E., Gascoyne Randy D., Weller Edie The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium Haematologica 2014;99 (4):715-725 [PubMed]
  • Kwee Thomas C., Vermoolen Malou A., Akkerman Erik A., Kersten Marie José, Fijnheer Rob, Ludwig Inge, Beek Frederik J. A., van Leeuwen Maarten S., Bierings Marc B., Bruin Marrie C. A., Zsíros József, Quarles van Ufford Henriëtte M. E., de Klerk John M. H., Adam Judit, Stoker Jaap, Uiterwaal Cuno S., Nievelstein Rutger A. J. Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: comparison with CT in a prospective multicenter study Journal of magnetic resonance imaging 2014;40 (1):26-36 [PubMed]

2013

  • Klodzinska S., Vos J. M. I., Kersten M. J., Wijermans P., Minnema M. C. A survey on diagnostic methods and treatment strategies used in patients with Waldenström's macroglobulinaemia in The Netherlands Netherlands journal of medicine 2013;71 (2):90-96 [PubMed]
  • Persoon Saskia, Kersten Marie José, van der Weiden Karen, Buffart Laurien M., Nollet Frans, Brug Johannes, Chinapaw Mai J. M. Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: a systematic review and meta-analysis Cancer treatment reviews 2013;39 (6):682-690 [PubMed]
  • Vos J. M. I., Minnema M. C., Wijermans P. W., Croockewit S., Chamuleau M. E. D., Pals S. T., Klein S. K., Delforge M., van Imhoff G. W., Kersten M. J. Guideline for diagnosis and treatment of Waldenström's macroglobulinaemia Netherlands journal of medicine 2013;71 (2):54-62 [PubMed]
  • Thielen Noortje, van der Holt Bronno, Verhoef Gregor E. G., Ammerlaan Rianne A. H. M., Sonneveld Pieter, Janssen Jeroen J. W. M., Deenik Wendy, Falkenburg J. H. Frederik, Kersten Marie José, Sinnige Harm A. M., Schipperus Martin, Schattenberg Anton, van Marwijk Kooy Rien, Smit Willem M., Chu Isabel W. T., Valk Peter J. M., Ossenkoppele Gert J., Cornelissen Jan J. High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group Annals of hematology 2013;92 (8):1049-1056 [PubMed]
  • Mank Arno P. M. High dose treatment for haematologic malignancies. From rituals to evidence based practice 2013. 215p. ISBN 9789461900296. [UvA Dissertations Online] University of Amsterdam. (Supervisor: van Oers M. H. J.; Co-supervisor: Kersten M. J.)
  • Kraan W., Horlings H. M., van Keimpema M., Schilder-Tol E. J. M., Oud M. E. C. M., Scheepstra C., Kluin P. M., Kersten M. J., Spaargaren M., Pals S. T. High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites Blood cancer journal 2013;3:e139 [PubMed]
  • van Dop Willemijn Alexandra, Kersten Marie-José, de Wever Bob, Hovius Joppe Willem Seronegative lyme neuroborreliosis in a patient using rituximab BMJ case reports 2013;2013:bcr2012007627 [PubMed]
  • Kocemba K. A., van Andel H., de Haan-Kramer A., Mahtouk K., Versteeg R., Kersten M. J., Spaargaren M., Pals S. T. The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis Leukemia 2013;27 (8):1729-1737 [PubMed]
  • Adams Hugo J. A., Kwee Thomas C., Vermoolen Malou A., de Keizer Bart, de Klerk John M. H., Adam Judit A., Fijnheer Rob, Kersten Marie José, Stoker Jaap, Nievelstein Rutger A. J. Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET European radiology 2013;23 (8):2271-2278 [PubMed]

2012

  • Chinapaw Mai J. M., Buffart Laurien M., van Mechelen Willem, Schep Goof, Aaronson Neil K., van Harten Wim H., Stuiver Martijn M., Kersten Marie José, Nollet Frans, Kaspers Gertjan J. L., van Dulmen-den Broeder Eline, Huisman Jaap, Takken Tim, van Tulder Maurits, Brug Johannes Alpe d'HuZes Cancer Rehabilitation (A-CaRe) Research: Four Randomized Controlled Exercise Trials and Economic Evaluations in Cancer Patients and Survivors International journal of behavioral medicine 2012;19 (2):143-156 [PubMed]
  • Sonneveld Pieter, Schmidt-Wolf Ingo G. H., van der Holt Bronno, el Jarari Laila, Bertsch Uta, Salwender Hans, Zweegman Sonja, Vellenga Edo, Broyl Annemiek, Blau Igor W., Weisel Katja C., Wittebol Shulamiet, Bos Gerard M. J., Stevens-Kroef Marian, Scheid Christof, Pfreundschuh Michael, Hose Dirk, Jauch Anna, van der Velde Helgi, Raymakers Reinier, Schaafsma Martijn R., Kersten Marie-Jose, van Marwijk-Kooy Marinus, Duehrsen Ulrich, Lindemann Walter, Wijermans Pierre W., Lokhorst Henk M., Goldschmidt Hartmut M. Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/GMMG-HD4 Trial Journal of clinical oncology 2012;30 (24):2946-2955 [PubMed]
  • van Maldegem F., Wormhoudt T. A. M., Mulder M. M. S., Oud M. E. C. M., Schilder-Tol E., Musler A. R., Aten J., Saeed P., Kersten M. J., Pals S. T., van Noesel C. J. M., Bende R. J. Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased V(H)4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment Leukemia 2012;26 (7):1647-1653 [PubMed]
  • Lokhorst Henk M., van der Holt Bronno, Cornelissen Jan J., Kersten Marie-José, van Oers Marinus, Raymakers Reinier, Minnema Monique C., Zweegman Sonja, Janssen Jeroen J., Zijlmans Mark, Bos Gerard, Schaap Nicolaas, Wittebol Shulamiet, de Weerdt Okke, Ammerlaan Rianne, Sonneveld Pieter Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study Blood 2012;119 (26):6219-6225 [PubMed]
  • Tonino Sanne H., van de Berg Pablo J., Yong Si La, ten Berge Ineke J., Kersten Marie José, van Lier René A. W., van Oers Marinus H., Kater Arnon P. Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia Leukemia & lymphoma 2012;53 (9):1785-1794 [PubMed]
  • van Dalen Elvira C., Mank Arno, Leclercq Edith, Mulder Renée L., Davies Michelle, Kersten Marie José, van de Wetering Marianne D. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia Cochrane database of systematic reviews (Online) 2012;2012 (9):CD006247 [PubMed]
  • Kersten M. J., Doorduijn J. K., de Jong D., Zijlstra-Baalbergen J. M., Ghidey W., Spiering M., Steijaert M., Meulendijks I., Hagenbeek A. ReBel studie: een gerandomiseerde fase I/II studie naar de effectiviteit en veiligheid van behandeling met lenalidomide en rituximab, met of zonder bendamustine, bij volwassen patienten met recidief folliculair lymfoom Nederlands tijdschrift voor hematologie 2012;9:71
  • Zweegman S., Lokhorst H. M., Levin M. D., de Waal E., Bos G. M., Kersten M. J., Ypma P., Klein S. K., Minnema M. C., Sonneveld P. Richtlijnen behandeling multipel myeloom 2012 Nederlands tijdschrift voor hematologie 2012;9:300
  • Vos J. M., Minnema M. C., Wijermans P. W., Croockewit S., Chamuleau M. E., Pals S. T., Klein S. K., Delforge M., van Imhoff G. W., Kersten M. J. Richtlijn voor diagnostiek en behandeling van de ziekte van Waldenström Nederlands tijdschrift voor hematologie 2012;9:219
  • Kocemba Kinga A., Groen Richard W. J., van Andel Harmen, Kersten Marie José, Mahtouk Karène, Spaargaren Marcel, Pals Steven T. Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma PLoS ONE 2012;7 (2):e30359 [PubMed]

2011

  • Tuinman P. R., Nieuwenhuis M. B. B., Groen E., Kersten M. J. A young woman with generalised lymphadenopathy. Systemic lupus erythematosus (SLE) Netherlands journal of medicine 2011;69 (6):284-288 [PubMed]
  • Zweegman S., Minnema M. C., Stevens-Kroef M., Kersten M. J., Wijermans P., Wegman Jurgen J., Regelink J. C., Brooimans R. A., Beverloo B., Bloem A. C., Lokhorst H. M., Sonneveld P., Raymakers R. A. P. Diagnostiek bij multipel myeloom: de rol van beeldvorming, chromosoomanalyse en multiparameterflowcytometrie Nederlands tijdschrift voor hematologie 2011;8 (4):146
  • Persoon S., Kersten M. J., Chinapaw M. J. M., Brug J., Nollet F. EXercise Intervention after Stem cell Transplantation (EXIST) Nederlands tijdschrift voor hematologie 2011;8 (3):125-129
  • Thai K. T. D., Wismeijer J. A., Zumpolle C., de Jong M. D., Kersten M. J., de Vries P. J. High incidence of peripheral blood plasmacytosis in patients with dengue virus infection Clinical microbiology and infection 2011;17 (12):1823-1828 [PubMed]
  • Ruinemans-Koerts Janneke, Boonstra J. G., Klasen I. S., Zweegman S., Minnema M. C., Wegman Jurgen J., Kersten M. J., Dinkelaar R. B., Wijermans P., Raymakers R. A. P. Laboratoriumonderzoek bij monoklonale gammopathie: detectie van monoklonale immuunglobulinen Nederlands tijdschrift voor hematologie 2011;8 (4):160
  • Kneppers Evelien, van der Holt Bronno, Kersten Marie-Jose, Zweegman Sonja, Meijer Ellen, Huls Gerwin, Cornelissen Jan J., Janssen Jeroen J., Huisman Cynthia, Cornelisse Petra B., Bruijnen Cheryl P., Emmelot Maarten, Sonneveld Pieter, Lokhorst Henk M., Mutis Tuna, Minnema Monique C. Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial Blood 2011;118 (9):2413-2419 [PubMed]
  • Hommes Daniel W., Duijvestein Marjolijn, Zelinkova Zuzana, Stokkers Pieter C. F., Ley Maartje Holsbergen-de, Stoker Jaap, Voermans Carlijn, van Oers Marinus H. J., Kersten Marie José Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease Journal of Crohn s & colitis 2011;5 (6):543-549 [PubMed]
  • Vermoolen Malou A., Kersten Marie José, Fijnheer Rob, van Leeuwen Maarten S., Kwee Thomas C., Nievelstein Rutger A. J. Magnetic resonance imaging of malignant lymphoma Expert review of hematology 2011;4 (2):161-171 [PubMed]
  • Kwee Thomas C., Akkerman Erik M., Fijnheer Rob, Kersten Marie José, Zsíros József, Ludwig Inge, Bierings Marc B., Vermoolen Malou A., van Leeuwen Maarten S., Stoker Jaap, Nievelstein Rutger A. J. MRI for staging lymphoma: whole-body or less? Journal of magnetic resonance imaging 2011;33 (5):1144-1150 [PubMed]
  • Groen Richard W. J., de Rooij Martin F. M., Kocemba Kinga A., Reijmers Rogier M., de Haan-Kramer Anneke, Overdijk Marije B., Aalders Linda, Rozemuller Henk, Martens Anton C. M., Bergsagel P. Leif, Kersten Marie José, Pals Steven T., Spaargaren Marcel N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation Haematologica 2011;96 (11):1653-1661 [PubMed]
  • Minnema M. C., van Dorp S., van de Donk N. W. C. J., Schouten F., Kersten M. J., Coenen J. L. L. M., Schouten H., Zweegman S., Schaafsma R., Lokhorst H. M. Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience Bone marrow transplantation 2011;46 (2):244-249 [PubMed]
  • Liu Roberto D. K., Buffart Laurien M., Kersten Marie José, Spiering Marjolein, Brug Johannes, van Mechelen Willem, Chinapaw Mai J. M. Psychometric properties of two physical activity questionnaires, the AQuAA and the PASE, in cancer patients BMC medical research methodology 2011;11:30 [PubMed]
  • Kersten Marie José Radioimmunotherapy in follicular lymphoma: Some like it hot… Transfusion and apheresis science : official journal of the World Apheresis Association 2011;44 (2):173-178 [PubMed]
  • Mank Arno, van der Lelie Johannes, de Vos Rien, Kersten Marie Jóse Safe early discharge for patients undergoing high dose chemotherapy with or without stem cell transplantation: a prospective analysis of clinical variables predictive for complications after treatment Journal of clinical nursing 2011;20 (3-4):388-395 [PubMed]
  • van Oers Marinus H. J., Kersten Marie José Treatment strategies in advanced stage follicular lymphoma Best practice & research. Clinical haematology 2011;24 (2):187-201 [PubMed]

2010

  • Kneppers Evelien, Lokhorst Henk M., Eeltink Corien M., Huls Gerwin, Kersten Marie José, Koedam Jan, Minnema Monique C., van Oers Marinus H. J., Raymakers Reinier A. P., Schaafsma Martijn R., Vellenga Edo, Wijermans Pierre W., Wittebol Shulamiet, Sonneveld Pieter, Zweegman Sonja Analysis of Efficacy and Prognostic Factors of Lenalidomide Treatment as Part of a Dutch Compassionate Use Program Clinical lymphoma, myeloma & leukemia 2010;10 (2):138-143 [PubMed]
  • Persoon Saskia, Kersten Marie Jose, Chinapaw Mai J. M., Buffart Laurien M., Burghout Heleen, Schep Goof, Brug Johannes, Nollet Frans Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of a individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin's lymphoma treated with high dose chemotherapy and autologous stem cell transplantation BMC cancer 2010;10 (1):671 [PubMed]
  • Khajouei R., Peek N., Wierenga P. C., Kersten M. J., Jaspers M. W. M. Effect of predefined order sets and usability problems on efficiency of computerized medication ordering International journal of medical informatics 2010;79 (10):690-698 [PubMed]
  • Deenik Wendy, Janssen Jeroen J. W. M., van der Holt Bronno, Verhoef Gregor E. G., Smit Willem M., Kersten Marie José, Daenen Simon M. G. J., Verdonck Leo F., Ferrant Augustin, Schattenberg Anton V. M. B., Sonneveld Pieter, van Marwijk Kooy Marinus, Wittebol Shulamit, Willemze Roelof, Wijermans Pierre W., Beverloo H. Berna, Löwenberg Bob, Valk Peter J. M., Ossenkoppele Gert J., Cornelissen Jan J. Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia Haematologica 2010;95 (6):914-921 [PubMed]
  • Broyl Annemiek, Hose Dirk, Lokhorst Henk, de Knegt Yvonne, Peeters Justine, Jauch Anna, Bertsch Uta, Buijs Arjan, Stevens-Kroef Marian, Beverloo H. Berna, Vellenga Edo, Zweegman Sonja, Kersten Marie-Josée, van der Holt Bronno, el Jarari Laila, Mulligan George, Goldschmidt Hartmut, van Duin Mark, Sonneveld Pieter Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients Blood 2010;116 (14):2543-2553 [PubMed]
  • Lokhorst H. M., von dem Borne P. A., Kersten M. J. HOVON 108: T-cel-gedepleteerde niet-myeloablatieve allogene stamceltransplantatie gevolgd door vroege consolidatie met lenalidomide of lenalidomide gecombineerd met bortezomib en aanvullend donorlymfocyteninfusie voor patiënten met een eerste recidief of progressie na eerstelijnsbehandeling Nederlands tijdschrift voor hematologie 2010;7 (8):332-338
  • Vlaar Alexander P. J., Porcelijn Leendert, van Rooijen-Schreurs Ingeborgh H. M., Lardy Neubury Maxton, Kersten Marie Jose, Juffermans Nicole P. The divergent clinical presentations of transfusion-related acute lung injury illustrated by two case reports Medical science monitor 2010;16 (10):CS129-CS134 [PubMed]

2009

  • Heutte Natacha, Flechtner Henning H., Mounier Nicolas, Mellink Wilhelmina A. M., Meerwaldt Jacobus H., Eghbali Houchingue, van't Veer Mars B., Noordijk Evert M., Kluin-Nelemans Johanna C., Lampka Elzbieta, Thomas José, Lugtenburg Pieternella J., Viterbo Luisa, Carde Patrice, Hagenbeek Anton, van der Maazen Richard Wm, Smit Wilma G. J. M., Brice Pauline, van Marwijk Kooy Marinus, Baars Johanna W., Poortmans Philip, Tirelli Umberto, Leeksma Onno C., Tomsic Radka, Feugier Pierre, Salles Gilles, Gabarre Jean, Kersten Marie José, van den Neste Eric, Creemers Geert-Jan M., Gaillard Isabelle, Meijnders Paul, Tertian Gérard, Reman Oumédaly, Muller Hein P., Troncy Jacques, Blanc Michel, Schroyens Wilfried, Voogt Paul J., Wijermans Pierre, Rieux Chantal, Fermé Christophe, Henry-Amar Michel Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial lancet oncology 2009;10 (12):1160-1170 [PubMed]
  • Kager Liesbeth M., Kersten Marie-Jose, Kloppenborg Raoul Peter, van Oers Rien, van den Born Bert-Jan Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma BMJ case reports 2009;2009:bcr06.2009.1926 [PubMed]

2008

  • Deenik Wendy, van der Holt Bronno, Verhoef Gregor E. G., Smit Willem M., Kersten Marie J., Kluin-Nelemans Hanneke C., Verdonck Leo F., Ferrant Augustin, Schattenberg Anton V. M. B., Janssen Jeroen J. W. M., Sonneveld Pieter, van Marwijk Kooy Marinus, Wittebol Shulamit, Willemze Roelof, Wijermans Pierre W., Westveer Petra H. M., Beverloo H. Berna, Valk Peter, Löwenberg Bob, Ossenkoppele Gert J., Cornelissen Jan J. Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia Blood 2008;111 (5):2581-2588 [PubMed]
  • Wever P. C., Bos J. C., van den Brekel M. W. M., de Jong D., Bovée L. P. M. J., Kersten M. J., Schellekens J. F. P., Kerst J. M. Een waarschijnlijk geval van difterie Tijdschrift voor infectieziekten 2008;3 (6):230-235
  • Minnema M. C., van de Donk N. W. C. J., Zweegman S., Hegenbart U., Schonland S., Raymakers R., Zijlmans J. M. J. M., Kersten M. J., Bos G. M. J., Lokhorst H. M. Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome Bone marrow transplantation 2008;41 (9):779-784 [PubMed]
  • Choi Goda, van den Borne Maaike P. J., Visser Caroline E., Kersten Marie Jose, Kater Arnon P. Invasive infections with a coagulase-negative staphylococcus in an immunocompromised patient: case report and review of the literature Annals of hematology 2008;87 (9):771-772 [PubMed]
  • van Gent Rogier, Kater Arnon P., Otto Sigrid A., Jaspers A., Borghans José A. M., Vrisekoop Nienke, Ackermans Mariëtte A. T., Ruiter An F. C., Wittebol Shulamiet, Eldering Eric, van Oers Marinus H. J., Tesselaar Kiki, Kersten Marie José, Miedema Frank In vivo Dynamics of Stable Chronic Lymphocytic Leukemia Inversely Correlate with Somatic Hypermutation Levels and Suggest No Major Leukemic Turnover in Bone Marrow Cancer research 2008;68 (24):10137-10144 [PubMed]
  • Lokhorst H. M., Zweegman S., Kersten M. J., Raymakers R. A. P., Vellenga E., Wittebol S., Sonneveld P. Richtlijnen behandeling multipel myeloom anno 2008 Nederlands tijdschrift voor hematologie 2008;5 (4):150
  • de Gorter David J. J., Reijmers Rogier M., Beuling Esther A., Naber Hildegonda P. H., Kuil Annemieke, Kersten Marie José, Pals Steven T., Spaargaren Marcel The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells Blood 2008;111 (7):3364-3372 [PubMed]

2007

  • Glas Annuska M., Knoops Laurent, Delahaye Leonie, Kersten Marie José, Kibbelaar Robby E., Wessels Lodewyk A., van Laar Ryan, van Krieken J. Han J. M., Baars Joke W., Raemaekers John, Kluin Philip M., van't Veer Laura J., de Jong Daphne Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma Journal of clinical oncology 2007;25 (4):390-398 [PubMed]
  • Rijneveld A. W., Koene H. R., Kersten M. J. Maligne lymfomen bij patienten met een hiv-infectie Tijdschrift voor infectieziekten 2007;2 (6):202-208
  • Rijneveld A. W., Koene H. R., Kersten M. J. Maligne lymfomen bij patienten met immuundeficientie ten gevolge van een hiv-infectie Nederlands tijdschrift voor hematologie 2007;4 (6):204-209
  • Kerst J. M., Heisterkamp S., de Jong D., Haas R. L. M., Kersten M. J. Nieuwe ontwikkelingen in de diagnostiek en primaire behandeling van indolent folliculair non-hodgkinlymfoom Nederlands tijdschrift voor hematologie 2007;4 (7):244-250
  • Klein Saskia K., Kersten Marie Jose Rituximab: standaardtherapie bij non-Hodgkin lymfoom Tijdschrift Kanker 2007;31:20

2005

  • Juffermans N. P., Jager A., Kersten M. J., van Oers M. H., Hommes D. W. Epstein-Barr-virus-gerelateerde lymfomen bij patiënten met inflammatoire darmziekte Nederlands tijdschrift voor geneeskunde 2005;149 (33):1859-1863 [PubMed]
  • Glas Annuska M., Kersten Marie José, Delahaye Leonie J. M. J., Witteveen Anke T., Kibbelaar Robby E., Velds Arno, Wessels Lodewyk F. A., Joosten Peter, Kerkhoven Ron M., Bernards René, van Krieken Johan H. J. M., Kluin Philip M., van't Veer Laura J., de Jong Daphne Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment Blood 2005;105 (1):301-307 [PubMed]
  • Deloose S. T. P., Smit L. A., Pals F. T., Kersten M.-J., van Noesel C. J. M., Pals S. T. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma Leukemia 2005;19 (5):851-855 [PubMed]
  • Kersten M. J. Monoklonale antilichaamtherapie bij B-cel chronische lymfatische leukemiein: G. Ossenkoppele, A. A. van de Loosdrecht, editors. Immuuntherapie van hematologische ziekten. Alphen aan de Rijn: Van Zuiden Communications; 2005. p. 41-46, ISBN 9789085230885
  • Gallegos Ruiz M. I., van Oers M. H. J., Kersten M. J. Rituximab: de 'magic bullet' in de bestrijding van het B-cel-non-Hodgkin-lymfoom? Werkingsmechanismen en mogelijke oorzaken van resistentie Nederlands tijdschrift voor hematologie 2005;2 (5):184-191
  • Kersten M. J. Rituximab immunotherapy in the treatment of B-cell non-Hodgkin's lymphoma European journal of hospital pharmacy 2005;II (4):18-19
  • Hunting C. B., Deloose S. T. P., de Valk B., Kersten M. J. Ziekte van Castleman Nederlands tijdschrift voor hematologie 2005;2 (1):22-27

2004

  • Kersten Marie José, de Jong Daphne, Raemaekers John M. M., Kluin Philip M., Hagenbeek Anton Beyond the International Prognostic Index: new prognostic factors in follicular lymphoma and diffuse large-cell lymphoma A meeting report of the Second International Lunenburg Lymphoma Workshop hematology journal 2004;5 (3):202-208 [PubMed]
  • de Jong D., Glas A., Kersten M. J. Genexpressieprofilering bij lymfomen Nederlands tijdschrift voor hematologie 2004 (3):106-112

2003

  • Verra N., Jansen R., Groenewegen G., Mallo H., Kersten M. J., Bex A., Vyth-Dreese F. A., Sein J., van de Kasteele W., Nooijen W. J., de Waal M., Horenblas S., de Gast G. C. Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma British journal of cancer 2003;88 (9):1346-1351 [PubMed]
  • Koopmans R. P., van den Born B. J., Kersten M. J., Hart W. Klinisch denken en beslissen in de praktijk. Een 41-jarige man met onbegrepen periodieke koorts Nederlands tijdschrift voor geneeskunde 2003;147 (37):1778-1783 [PubMed]
  • Kok Marleen, Bonfrer Johannes M., Korse Catharina M., de Jong Daphne, Kersten Marie José Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma Tumour biology 2003;24 (1):53-60 [PubMed]
  • de Gast G. C., Batchelor D., Kersten M. J., Vyth-Dreese F. A., Sein J., van de Kasteele W. F., Nooijen W. J., Nieweg O. E., de Waal M. A., Boogerd W. Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma British journal of cancer 2003;88 (2):175-180 [PubMed]
  • de Jong Daphne, Glas Annuska M., Boerrigter Lucie, Hermus Marie-Christine, Dalesio Otilia, Willemse Els, Nederlof Petra M., Kersten Marie José Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features Blood 2003;102 (1):324-327 [PubMed]

2001

  • Kersten M. J., van Oers R. H. Management of AIDS-related non-Hodgkin's lymphomas Drugs 2001;61 (9):1301-1315 [PubMed]

2000

  • van Baarle D., Hovenkamp E., Dukers N. H., Renwick N., Kersten M. J., Goudsmit J., Coutinho R. A., Miedema F., van Oers M. H. High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission Journal of infectious diseases 2000;181 (6):2045-2049 [PubMed]
  • de Gast G. C., Klümpen H. J., Vyth-Dreese F. A., Kersten M. J., Verra N. C., Sein J., Batchelor D., Nooijen W. J., Schornagel J. H. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma Clinical cancer research 2000;6 (4):1267-1272 [PubMed]

1999

  • Berger C., van Baarle D., Kersten M. J., Klein M. R., Al-Homsi A. S., Dunn B., McQuain C., van Oers R., Knecht H. Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification Journal of infectious diseases 1999;179 (1):240-244 [PubMed]
  • van Baarle D., Hovenkamp E., Kersten M. J., Klein M. R., Miedema F., van Oers M. H. Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: no association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma Blood 1999;93 (11):3949-3955 [PubMed]
  • Kersten M. J., Surachno S., Koopman M. G., van 't Veer L. J., Pals S. T., van Oers M. H. Epstein-Barr-virus in een donornier als oorzaak van non-Hodgkin-lymfoom Nederlands tijdschrift voor geneeskunde 1999;143 (7):360-364 [PubMed]

1998

  • Kersten M. J., van Gorp J., Pals S. T., Boon F., van Oers M. H. Expression of Epstein-Barr virus latent genes and adhesion molecules in AIDS-related non-Hodgkin's lymphomas: correlation with histology and CD4-cell number Leukemia & lymphoma 1998;30 (5-6):515-524 [PubMed]
  • Al-Homsi A. S., Berger C., van Baarle D., Kersten M. J., Klein M. R., McQuain C., van Oers R., Knecht H. Molecular analysis of critical sequences within the EBNA-2 type 1 gene from Epstein-Barr virus isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV infection International journal of molecular medicine 1998;1 (6):983-987 [PubMed]
  • Kersten M. J., Verduyn T. J., Reiss P., Evers L. M., de Wolf F., van Oers M. H. Treatment of AIDS-related non-Hodgkin's lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: clinical outcome and effect on HIV-1 viral load Annals of oncology 1998;9 (10):1135-1138 [PubMed]

1997

  • Kersten M. J., de Jong S., Evers L. M., Koene H. R., van Oers M. H. Addition of granulocyte colony-stimulating factor to chemotherapy in patients with AIDS-related lymphoma: effects on neutrophil Fc gamma receptor expression and soluble Fc gammaRIII plasma levels British journal of haematology 1997;99 (3):537-541 [PubMed]
  • Kersten M. J., Klein M. R., Holwerda A. M., Miedema F., van Oers M. H. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma Journal of clinical investigation 1997;99 (7):1525-1533 [PubMed]
  • Feltkamp M. C., Kersten M. J., van der Lelie J., Burggraaf J. D., de Hoog G. S., Kuijper E. J. Fatal Scedosporium prolificans infection in a leukemic patient European journal of clinical microbiology & infectious diseases 1997;16 (6):460-464 [PubMed]

1996

  • Kersten M. J., Evers L. M., Dellemijn P. L., van den Berg H., Portegies P., Hintzen R. Q., van Lier R. A., von dem Borne A. E., van Oers R. H. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies Blood 1996;87 (5):1985-1989 [PubMed]
  • Kersten M. J., Lange R., Smeets M. E., Vreugdenhil G., Roozendaal K. J., Lameijer W., Goudsmit R. Long-term treatment of transfusional iron overload with the oral iron chelator deferiprone (L1): a Dutch multicenter trial Annals of hematology 1996;73 (5):247-252 [PubMed]

1993

  • Kersten M. J., Mertens M. J., Pals S. T., Reiss P., van Oers M. H. Met HIV samenhangend non-Hodgkin-lymfoom bij 45 patiënten; een retrospectieve analyse Nederlands tijdschrift voor geneeskunde 1993;137 (28):1396-1400 [PubMed]

1990

  • Hollak C. E., Kersten M. J., van der Lelie J., Lange J. M. Thrombocytopenic purpura as first manifestation of human immunodeficiency virus type I (HIV-1) infection Netherlands journal of medicine 1990;37 (1-2):63-68 [PubMed]

1989

  • Huisman M. V., Büller H. R., ten Cate J. W., van Royen E. A., Vreeken J., Kersten M. J., Bakx B. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis Chest 1989;95 (3):498-502 [PubMed]